RevolKa Reimagines Antibody Engineering with "RevoAb®"

Contributed by: Business Wire

Logo

Tags

Software

Research

Professional Services

Pharmaceutical

Data Management

Start-Up

Technology

University

Artificial Intelligence

Education

Science

Biotechnology

Health

RevoAb

More Like This

'RevoAb™', A New Service for Antibody Developability Engineering

Proteintech Launches “Able” AI – A First-of-Its-Kind Tool to Accelerate Scientific Discovery

PR Newswire associated0

Accelerating Drug Discovery: Tsingke Biotech Unveils Next-Generation Rapid Protein and Antibody Solutions

LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes

PR Newswire associated0

mAIbe and LenioBio announce a new strategic collaboration aimed at accelerating the discovery and experimental validation of next-generation monoclonal antibodies

PR Newswire associated0

Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA

On the Proteintech website (ptglab.com), researchers can explore antibody binding sites with the new interactive 3D epitope viewer. (Photo: Business Wire)

Proteintech Unveils Next-Gen 3D Epitope Mapping to Accelerate Life Science Research

Proteintech Genomics' MultiPro™ Human Fixed Cell Immune Profiling Antibody Cocktail containing 53 antibodies against intracellular and cell surface proteins, plus 5 isotype controls (Photo: Business Wire)

Proteintech Genomics Launches First Commercially Available Solution for the Detection of Intracellular Proteins for Single-Cell RNAseq Experiments